FDA rejects Scholar Rock's apitegromab application due to facility issues
Go back to FDA rejects Scholar Rock's apitegromab application due to facility issues| (NASDAQ: SRRK) | Delayed: 55.67 +1.05 (1.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.62 | 52 Week High | $ | |||
| Open | $54.01 | 52 Week Low | $ | |||
| Day High | $56.71 | P/E | N/A | |||
| Day Low | $53.86 | EPS | $ | |||
| Volume | 946,629 | |||||
